default author photo

Bright Lipenga

University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme

P.O. Box 30096, Chichiri

Blantyre 3, Malawi

Blantyre

Malawi

  • University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme

SCHOLARLY PAPERS

2

DOWNLOADS

133

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Immunogenicity and Reactogenicity of a Booster Dose of a Typhoid Conjugate Vaccine (TCV) in Malawian Pre-School Children

Number of pages: 30 Posted: 28 Oct 2024
Nginache Nampota-Nkomba, Osward M. Nyirenda, Shrimati Datta, Victoria Mapemba, Priyanka D. Patel, Theresa Misiri, Felistas Mwakisighile, John Ndaferankhande, Bright Lipenga, Jennifer Oshinsky, Marcella Pasetti, Leslie P. Jamka, Melita A. Gordon, Matthew B. Laurens and Kathleen Neuzil
Kamuzu University of Health Sciences - Blantyre Malaria Project, Kamuzu University of Health Sciences - Blantyre Malaria Project, - Center for Vaccine Development and Global Health, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, - Center for Vaccine Development and Global Health, University of Maryland School of Medicine - Center for Vaccine Development and Global Health, - Center for Vaccine Development and Global Health, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Maryland, Baltimore (UMB) - School of Medicine and Gates Foundation
Downloads 78 (823,616)

Abstract:

Loading...

Typhoid conjugate vaccine, Salmonella enterica, Salmonella Typhi, typhoid fever, Malawi, Africa, booster dose, immunogenicity, tetanus, enteric fever, invasive bacterial infection

2.

Whole Cell Inactivated Poly-Bacterial Preparation MV130 Effect on Nasal Mucosal Immunity and Experimental Human Pneumococcal Carriage: Double-Blind Randomized Controlled Trial with Controlled Human Infection Model ​

Number of pages: 29 Posted: 17 Mar 2026
John Ndaferankhande, Kondwani Jambo, Tarsizio Chikaonda, Godwin Tembo, Laura Conejero, Marc YR Henrion, Evaristar Kudowa, Gareth Lipunga, Anthony Emeritus Chirwa, Edna Nsomba, Mphatso Chaponda, Mphatso Mailboy, Andrew Sigoloti, Shalom Songolo, Neema Toto, Faith Thole, Ndaziona Peter Banda, Bridgette Galafa, Glory Kadzanja, Morrison P. Kamanga, Lorensio Chimgoneko, Tiyamika Nthandira, Benson M. Tembo, Alfred Muyaya, Lumbani Makhaza, Bright Lipenga, Vusumuzi Katangwe, Gift Chiwala, Jonathan Grigg and Stephen B. Gordon
University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Immunotek, S.L., University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Queen Mary University of London and University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Downloads 55 (1,097,529)

Abstract:

Loading...

trained immunity, vaccine, CHIM, mucosal immunity, Streptococcus pneumoniae